YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2025Lazertinib Versus Osimertinib in Previously Untreated EGFR-Mutant Advanced NSCLC: A Randomized, Double-Blind, Exploratory Analysis From MARIPOSA JOURNAL OF THORACIC ONCOLOGY
2025Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18EUROPEAN JOURNAL OF CANCER
2025Pegylated granulocyte colony-stimulating factor primary prophylaxis versus no prophylaxis in patients with unresectable pancreatic cancer treated with modified-FOLFIRINOX: a randomized, open-label, multicenter, phase 2 trial ECLINICALMEDICINE
2025Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyLUNG CANCER
2025The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2025Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study DIABETES THERAPY
2025First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trialEUROPEAN JOURNAL OF CANCER
2026Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naïve type 2 diabetes: The EMPA-FIT studyJOURNAL OF DIABETES AND ITS COMPLICATIONS
2026Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial DIABETES OBESITY & METABOLISM
2025Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21) ESMO OPEN
2025Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis ANNALS OF ONCOLOGY
2025Touch Me Not! Exploring the Devastating Stigma on People Living with HIV INFECTION AND CHEMOTHERAPY
2025Association between Albumin Administration and Pulmonary Complications in Patients with Septic Shock: An Analysis Using the MIMIC-IV Database INFECTION AND CHEMOTHERAPY
2025Ticagrelor Monotherapy vs. Ticagrelor With Aspirin in Bleeding and Cardiovascular Events in Acute Coronary Syndrome Patients According to Renal Function: The Subanalysis From the TICO Trial KOREAN CIRCULATION JOURNAL
2025Pulsed field ablation vs high-power short duration/very high-power short duration pulmonary vein isolation-Systematic review and meta-analysis with Kaplan-Meier reconstructed individual patient data HEART RHYTHM
2025Na+/H+ Exchanger 1 Inhibition Overcomes Venetoclax Resistance in Acute Myeloid Leukemia CELLS(Cells)
2025Balancing safety and effectiveness in colonoscopy for older adults: a narrative review INTESTINAL RESEARCH
2025Utilization of cell-free DNA metagenomic analysis for early detection and microbial identification in prosthetic joint infections: a prospective cohort study in Korea FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2025Defining Severe Diabetes Mellitus: A Consensus Framework for Grading and Staging Diabetes Based on Pathophysiology and Complications DIABETES & METABOLISM JOURNAL
2025Comparative Analysis of the Risk of Rebleeding between Catheter Angiography and Colonoscopy Followinga Positive Computed Tomography Angiography Results in Patients with Severe Lower Gastrointestinal Bleeding GUT AND LIVER
1234567891011 771

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links